Need more? Try out  Advanced Search (20+ criteria)»

Last Update

is this you? Claim your profile.

Wrong Michael Riebe?

Michael T. Riebe

Senior Vice President Pharmaceutical Development and Research

Pearl Therapeutics , Inc.

HQ Phone:  (650) 305-2600

Direct Phone: (919) ***-****direct phone

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Pearl Therapeutics , Inc.

200 CARDINAL WAY

Redwood City, California,94063

United States

Company Description

Pearl Therapeutics is a privately held company developing combination therapies for the treatment of highly prevalent respiratory diseases, including chronic obstructive pulmonary disease and asthma. Pearl is rapidly advancing a pipeline of products including ... more.

Find other employees at this company (261)

Background Information

Employment History

Vice President of Research and Development

iCeutica Inc


Senior Director

Merck & Co. , Inc.


Director

RTI International


Position, Respiratory Product Development

GlaxoSmithKline plc


Director

Glaxo Wellcome Inc.


Web References(17 Total References)


News 2013 Archives - nlvpartners

www.nlvpartners.com [cached]

Pearl Therapeutics Strengthens Its Organization by Hiring Dr. Michael Riebe, an Industry Veteran in Respiratory Product Development REDWOOD CITY, CALIF., January 17, 2013 - Pearl Therapeutics Inc. today announced that Michael Riebe, Ph.D. has joined Pearl...


www.oindpnews.com

Pearl Therapeutics hires Michael Riebe | Pearl Therapeutics hires Michael Riebe | . . . Read more
Pearl Therapeutics hires Michael Riebe | Pearl Therapeutics hires Michael Riebe | . . . Read more Pearl Therapeutics hires Michael Riebe Jan 172013 Pearl Therapeutics, which is developing several inhaled drugs, has announced that it has hired Michael Riebe as VP, Pharmaceutical Development and Research, effective immediately. Riebe, a past chair and current steering committee member of the AAPS Inhalation and Nasal Technology Focus Group, was most recently VP of Research and Development at iCeutica and previously worked in inhaled drug development at Merck and at Glaxo. Speaking for the management and board of directors, we welcome Mike to the Pearl team."


NewMexicoLifeScience.com

www.newmexicolifescience.com [cached]

Pearl Therapeutics appoints Dr. Michael Riebe VP as pharmaceutical development & research Pearl Therapeutics announced the appointment of Michael Riebe, Ph.D. as VP, pharmaceutical development and research.
Prior to joining Pearl Therapeutics, Dr. Riebe was VP of R&D at iCeutica where he led development of the Company's pipeline of pain, oncology and respiratory products.


New Leaf Venture Partners :: a leader in healthcare technology venture investing

www.nlvpartners.com [cached]

REDWOOD CITY, CALIF., January 17, 2013 - Pearl Therapeutics Inc. today announced that Michael Riebe, Ph.D. has joined Pearl Therapeutics as vice president, pharmaceutical development and research, effective immediately.
Speaking for the management and board of directors, we welcome Mike to the Pearl team." Prior to joining Pearl Therapeutics, Dr. Riebe was vice president of research and development at iCeutica where he led development of the Company's pipeline of pain, oncology and respiratory products. Prior to iCeutica, Dr. Riebe held various roles at Merck, most recently senior scientific director in respiratory product development; and at RTI, an independent, nonprofit research and development organization. From 1990 through 2003, Dr. Riebe held several positions in respiratory product development at GlaxoSmithKline and its predecessor, Glaxo Wellcome, where he led project teams responsible for pharmaceutical development of Serevent®, Ventolin® HFA, and Seretide®/Advair® HFA. Dr. Riebe received his B.A. degree in chemistry from Kalamazoo College and his Ph.D. in analytical chemistry from the University of Wisconsin - Madison. He has served in numerous leadership positions within the American Chemical Society and the American Association for Pharmaceutical Scientists, including as chairman of the AAPS Inhalation and Nasal Technology Focus Group.


News » OINDPnews » Page 3

www.oindpnews.com [cached]

Pearl Therapeutics hires Michael Riebe
Jan 172013 Pearl Therapeutics, which is developing several inhaled drugs, has announced that it has hired Michael Riebe as VP, Pharmaceutical Development and Research, effective immediately. Riebe, a past chair and current steering committee member of the AAPS Inhalation and Nasal Technology Focus Group, was most recently VP of Research and Development at iCeutica and previously worked . . . Read more


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory